We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Understanding Perrigo (PRGO) Reliance on International Revenue
Read MoreHide Full Article
Have you evaluated the performance of Perrigo's (PRGO - Free Report) international operations during the quarter that concluded in March 2024? Considering the extensive worldwide presence of this drug company, analyzing the patterns in international revenues is crucial for understanding its financial resilience and potential for growth.
In the current era of a tightly interconnected global economy, the proficiency of a company to penetrate international markets significantly influences its financial health and trajectory of growth. For investors, the key is to grasp how reliant a company is on overseas markets, as this provides insights into the durability of its earnings, its ability to exploit different economic cycles, and its overall growth capabilities.
Being present in foreign markets serves as protection against local economic declines and helps benefit from more rapidly expanding economies. Yet, such expansion also introduces challenges related to currency fluctuations, geopolitical uncertainties and varied market behaviors.
Upon examining PRGO's recent quarterly performance, we noticed several interesting patterns in the revenue generated from its international segments, which are commonly analyzed and observed by Wall Street experts.
The company's total revenue for the quarter amounted to $1.08 billion, marking a decrease of 8.4% from the year-ago quarter. We will next turn our attention to dissecting PRGO's international revenue to get a clearer picture of how significant its operations are outside its main base.
Decoding PRGO's International Revenue Trends
All other countries accounted for 2.8% of the company's total revenue during the quarter, translating to $30.1 million. Revenues from this region represented a surprise of -14.46%, with Wall Street analysts collectively expecting $35.19 million. When compared to the preceding quarter and the same quarter in the previous year, All other countries contributed $26.5 million (2.3%) and $24.4 million (2.1%) to the total revenue, respectively.
Europe generated $419.7 million in revenues for the company in the last quarter, constituting 38.8% of the total. This represented a surprise of +14.04% compared to the $368.04 million projected by Wall Street analysts. Comparatively, in the previous quarter, Europe accounted for $389.9 million (33.7%), and in the year-ago quarter, it contributed $407.3 million (34.5%) to the total revenue.
Revenue Projections for Overseas Markets
The current fiscal quarter's total revenue for Perrigo, as projected by Wall Street analysts, is expected to reach $1.17 billion, reflecting a decline of 2.3% from the same quarter last year. The breakdown of this revenue by foreign region is as follows: All other countries is anticipated to contribute 3.4% or $39.12 million and Europe 34.5% or $401.78 million.
Analysts expect the company to report a total annual revenue of $4.64 billion for the full year, marking a decrease of 0.4% compared to last year. The expected revenue contributions from All other countries and Europe are projected to be 3.3% ($152.59 million) and 34% ($1.58 billion) of the total revenue, in that order.
The Bottom Line
Perrigo's reliance on international markets for revenues offers both opportunities and risks. Hence, keeping an eye on its international revenue trends could significantly help forecast the company's prospects.
In an era of growing international ties and escalating geopolitical disputes, financial analysts on Wall Street pay keen attention to these developments to fine-tune their earnings estimations for businesses operating across borders. It's important to note, however, that a range of additional variables, like a company's local market status, also play a crucial role in shaping these forecasts.
Here at Zacks, we put a great deal of emphasis on a company's changing earnings outlook, as empirical research has shown that's a powerful force driving a stock's near-term price performance. Quite naturally, the correlation is positive here -- an upward revision in earnings estimates drives the stock price higher.
The Zacks Rank, our proprietary stock rating tool, comes with an externally validated impressive track record. It effectively utilizes shifts in earnings projections to act as a dependable barometer for forecasting short-term stock price trends.
Over the past month, the stock has seen an increase of 1.3% in its value, whereas the Zacks S&P 500 composite has posted an increase of 1.3%. The Zacks Medical sector, Perrigo's industry group, has ascended 1.7% over the identical span. In the past three months, there's been a decline of 4.1% in the company's stock price, against a rise of 4.3% in the S&P 500 index. The broader sector has declined by 1% during this interval.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Understanding Perrigo (PRGO) Reliance on International Revenue
Have you evaluated the performance of Perrigo's (PRGO - Free Report) international operations during the quarter that concluded in March 2024? Considering the extensive worldwide presence of this drug company, analyzing the patterns in international revenues is crucial for understanding its financial resilience and potential for growth.
In the current era of a tightly interconnected global economy, the proficiency of a company to penetrate international markets significantly influences its financial health and trajectory of growth. For investors, the key is to grasp how reliant a company is on overseas markets, as this provides insights into the durability of its earnings, its ability to exploit different economic cycles, and its overall growth capabilities.
Being present in foreign markets serves as protection against local economic declines and helps benefit from more rapidly expanding economies. Yet, such expansion also introduces challenges related to currency fluctuations, geopolitical uncertainties and varied market behaviors.
Upon examining PRGO's recent quarterly performance, we noticed several interesting patterns in the revenue generated from its international segments, which are commonly analyzed and observed by Wall Street experts.
The company's total revenue for the quarter amounted to $1.08 billion, marking a decrease of 8.4% from the year-ago quarter. We will next turn our attention to dissecting PRGO's international revenue to get a clearer picture of how significant its operations are outside its main base.
Decoding PRGO's International Revenue Trends
All other countries accounted for 2.8% of the company's total revenue during the quarter, translating to $30.1 million. Revenues from this region represented a surprise of -14.46%, with Wall Street analysts collectively expecting $35.19 million. When compared to the preceding quarter and the same quarter in the previous year, All other countries contributed $26.5 million (2.3%) and $24.4 million (2.1%) to the total revenue, respectively.
Europe generated $419.7 million in revenues for the company in the last quarter, constituting 38.8% of the total. This represented a surprise of +14.04% compared to the $368.04 million projected by Wall Street analysts. Comparatively, in the previous quarter, Europe accounted for $389.9 million (33.7%), and in the year-ago quarter, it contributed $407.3 million (34.5%) to the total revenue.
Revenue Projections for Overseas Markets
The current fiscal quarter's total revenue for Perrigo, as projected by Wall Street analysts, is expected to reach $1.17 billion, reflecting a decline of 2.3% from the same quarter last year. The breakdown of this revenue by foreign region is as follows: All other countries is anticipated to contribute 3.4% or $39.12 million and Europe 34.5% or $401.78 million.
Analysts expect the company to report a total annual revenue of $4.64 billion for the full year, marking a decrease of 0.4% compared to last year. The expected revenue contributions from All other countries and Europe are projected to be 3.3% ($152.59 million) and 34% ($1.58 billion) of the total revenue, in that order.
The Bottom Line
Perrigo's reliance on international markets for revenues offers both opportunities and risks. Hence, keeping an eye on its international revenue trends could significantly help forecast the company's prospects.
In an era of growing international ties and escalating geopolitical disputes, financial analysts on Wall Street pay keen attention to these developments to fine-tune their earnings estimations for businesses operating across borders. It's important to note, however, that a range of additional variables, like a company's local market status, also play a crucial role in shaping these forecasts.
Here at Zacks, we put a great deal of emphasis on a company's changing earnings outlook, as empirical research has shown that's a powerful force driving a stock's near-term price performance. Quite naturally, the correlation is positive here -- an upward revision in earnings estimates drives the stock price higher.
The Zacks Rank, our proprietary stock rating tool, comes with an externally validated impressive track record. It effectively utilizes shifts in earnings projections to act as a dependable barometer for forecasting short-term stock price trends.
Perrigo, bearing a Zacks Rank #3 (Hold), is expected to mirror the broader market's movements in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Perrigo's Recent Stock Market Performance
Over the past month, the stock has seen an increase of 1.3% in its value, whereas the Zacks S&P 500 composite has posted an increase of 1.3%. The Zacks Medical sector, Perrigo's industry group, has ascended 1.7% over the identical span. In the past three months, there's been a decline of 4.1% in the company's stock price, against a rise of 4.3% in the S&P 500 index. The broader sector has declined by 1% during this interval.